Amgen broke ground in late July of 2019 on a $200 million biomanufacturing center in West Greenwich, R.I. Featuring a highly flexible, modular design, the next-generation facility will leverage advanced technologies to reduce operational expenses, consume 80 percent less energy and water, and achieve a 75 percent decrease in carbon emissions.
DLJ Real Estate Capital Partners and Leggat McCall Properties are building a Class-A laboratory building in Somerville, Mass. The nine-story, 289,000-sf facility will provide leading-edge research and office space for life sciences and technology companies. The mixed-use development will include dedicated retail space on the ground floor and four levels of underground parking.
HALIX is constructing a 72,000-sf cGMP facility at Leiden Bio Science Park in the Netherlands. Utilizing 1000-liter, single-use bioreactors, the five-story building will accommodate the development and manufacture of biopharmaceutical drug substances for clinical and commercial applications. Housing labs for process development, analytical development, and quality control, the structure will feature cleanrooms with unidirectional process flows with separate areas for protein manufacturing and the production of viral vaccines and viral vectors.
Adaptive Biotechnologies is expanding its presence in Seattle with the lease of a 100,000-sf headquarters building in Seattle. The lab and office facility is located in the Lake Union life science district and is being developed by Alexandria Real Estate Equities. Adaptive will occupy the entire structure, which is sited adjacent to its existing facility. Building amenities will include an open-air plaza, a rooftop desk, a fitness center, locker and shower rooms, and direct access to water sports on Lake Union.
Foundation Medicine will locate its 580,000-sf life science headquarters in a planned 625,000-sf building in Boston's Seaport Square. Designed by Morris Adjmi Architects and Stantec, the leased building will provide leading-edge research, collaboration, and administrative facilities to support the creation of innovative biomedical therapies.
Procter & Gamble is engaged in a $50 million renovation and expansion of the Reading Gillette Innovation Centre in the United Kingdom. The project includes the construction of new research labs and the renovation of an existing building and associated warehouses to create a two-story, 75,300-sf complex to house the Health Care Innovation Laboratories. Completion is expected in late 2019 with occupancy in 2020.
ADC Bio completed construction of a £5 million bioconjugation cleanroom in July of 2019. Located within the company's 70,000-sf facility in Deeside in the United Kingdom, the GMP lab will support the commercial manufacture of innovative antibody-drug conjugates for the treatment of cancer. Designed and constructed by WHP Engineering, the project houses Grade C and D cleanrooms with four-zone HVAC systems for optimal environmental containment.
Wexford Science+Technology opened the $88 million Wexford Innovation Center in July of 2019 in Providence, R.I. Designed by Ayers Saint Gross, the seven-story, 202,000-sf building will accommodate tenants including Brown University's School of Professional Studies, the Cambridge Innovation Center, Johnson & Johnson, the Venture Café, and The Boston Globe. Interior improvements valued at $17 million were performed for the Cambridge Innovation Center's facilities.
Premier BioSource opened a 78,000-sf swine production facility in July of 2019 in Rensselaer, Ind. Designed as a barrier facility with advanced HEPA filtration and positive air pressure systems, the $7.5 million farrow-to-finish complex will enable biomedical research on the creation of organs for xenotransplantation in humans. Supporting lean manufacturing operations, the biocontainment facility features advanced building systems including individual controls for the air pressure in each room and an energy recovery wheel for optimal heat exchange.
NorthStar Medical Radioisotopes completed construction in July of 2019 on a 20,000-sf production facility in Beloit, Wis. Featuring the company's RadioGenix® System, the project features state-of-the-art dissolution and source vessel filling equipment for the processing of molybdenum-99 (Mo-99) to support the creation of technetium-99m (Tc-99m) for diagnostic imaging applications. The facility also houses a quality control lab, an automated packaging line, and an advanced molybdenum recycling complex.
The University of Cambridge will break ground in November of 2019 on the Heart and Lung Research Institute in Cambridge in the United Kingdom. Sited adjacent to the Royal Papworth Hospital on the Cambridge Biomedical Campus, the facility will accommodate 380 academic and industry scientists engaged in the discovery of new therapeutics and diagnostic tools for cardiovascular conditions.
NeoGenomics will break ground in late 2019 on a $55 million oncology laboratory and global headquarters facility in Fort Myers, Fla. Designed by Studio Plus, the 150,000-sf facility will provide the comprehensive cancer diagnostics company with research and administrative space for up to 575 employees. Located on a 14-acre parcel, the building will support clinical trials of new oncology therapeutics with a state-of-the-art molecular lab with next-generation sequencing capabilities.
ElevateBio has selected DPS Group and TRIA to design ElevateBio BaseCamp, a 108,000-sf cGMP development and manufacturing facility in Waltham. Located in a 430,000-sf office and lab building, the facility will offer integrated R&D, process development, and cGMP manufacturing services for novel therapeutic technologies.
The University of Windsor celebrated the opening of the CAD$30 million Essex Centre of Research (CORe) in June of 2019 in Windsor, Ontario. Designed by NORR and Hariri Pontarini Architects, the 46,000-sf facility was constructed as an addition to Essex Hall and provides collaborative wet and dry laboratories for the study of advanced materials, transitional health, and medical physics.
Texas A&M University opened the $104 million Medical Research and Education Building II (MREB II) in June of 2019 in Bryan, Texas. Designed by Flad Architects and OMNIPLAN, the 155,077-sf project comprises a 48,200-sf vertical expansion to the existing Medical Research and Education Building (MREB I) and a 122,800-sf addition, enabling the College of Medicine's basic science departments to be collocated in a single campus.
